KR850002744A - 삼-치환 이미다졸 유도체의 제조방법 - Google Patents
삼-치환 이미다졸 유도체의 제조방법Info
- Publication number
- KR850002744A KR850002744A KR1019840005960A KR840005960A KR850002744A KR 850002744 A KR850002744 A KR 850002744A KR 1019840005960 A KR1019840005960 A KR 1019840005960A KR 840005960 A KR840005960 A KR 840005960A KR 850002744 A KR850002744 A KR 850002744A
- Authority
- KR
- South Korea
- Prior art keywords
- tri
- preparing
- imidazole derivative
- substituted imidazole
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019840005960A KR850000873B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH571580 | 1980-07-25 | ||
CH5715 | 1980-07-25 | ||
KR1019810002709A KR850000883B1 (ko) | 1980-07-25 | 1981-07-25 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005960A KR850000873B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810002709A Division KR850000883B1 (ko) | 1980-07-25 | 1981-07-25 | 삼-치환 이미다졸 유도체의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850002744A true KR850002744A (ko) | 1985-05-15 |
KR850000873B1 KR850000873B1 (ko) | 1985-06-22 |
Family
ID=4298165
Family Applications (13)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810002709A KR850000883B1 (ko) | 1980-07-25 | 1981-07-25 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005962A KR850000885B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005972A KR850001064B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005971A KR850000892B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005966A KR850000889B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005968A KR850000890B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005960A KR850000873B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005961A KR850000884B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005964A KR850000887B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005965A KR850000888B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005970A KR850000911B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 옥사졸 유도체의 제조방법 |
KR1019840005969A KR850000891B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005963A KR850000886B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810002709A KR850000883B1 (ko) | 1980-07-25 | 1981-07-25 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005962A KR850000885B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005972A KR850001064B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005971A KR850000892B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005966A KR850000889B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005968A KR850000890B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840005961A KR850000884B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005964A KR850000887B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005965A KR850000888B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005970A KR850000911B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 옥사졸 유도체의 제조방법 |
KR1019840005969A KR850000891B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
KR1019840005963A KR850000886B1 (ko) | 1980-07-25 | 1984-09-27 | 삼-치환 이미다졸 유도체의 제조방법 |
Country Status (23)
Country | Link |
---|---|
US (1) | US4447431A (ko) |
EP (1) | EP0045081B1 (ko) |
JP (1) | JPS5756466A (ko) |
KR (13) | KR850000883B1 (ko) |
AR (1) | AR230269A1 (ko) |
AT (1) | ATE17349T1 (ko) |
AU (2) | AU7340481A (ko) |
CA (1) | CA1175431A (ko) |
DD (2) | DD201677A5 (ko) |
DE (1) | DE3173434D1 (ko) |
DK (1) | DK331881A (ko) |
ES (8) | ES8301472A1 (ko) |
FI (1) | FI812326L (ko) |
GB (1) | GB2080805B (ko) |
GR (1) | GR75287B (ko) |
IE (1) | IE52071B1 (ko) |
IL (1) | IL63410A (ko) |
NO (1) | NO812542L (ko) |
NZ (1) | NZ197828A (ko) |
PL (8) | PL237000A1 (ko) |
PT (1) | PT73424B (ko) |
SU (8) | SU1235454A3 (ko) |
ZA (1) | ZA815078B (ko) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2123831B (en) * | 1981-07-20 | 1986-01-15 | Ciba Geigy Ag | Trisubstituted oxazo compounds |
EP0084756A1 (de) * | 1982-01-22 | 1983-08-03 | Ciba-Geigy Ag | Trisubstituierte Oxazaverbindungen |
FR2633291B1 (fr) * | 1988-06-27 | 1990-09-07 | Oreal | Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant |
US5252322A (en) * | 1989-09-22 | 1993-10-12 | The Gillette Company | Skin tanning compositions containing imidazoles |
NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
MX9300141A (es) * | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
US5593991A (en) * | 1993-07-16 | 1997-01-14 | Adams; Jerry L. | Imidazole compounds, use and process of making |
US5670527A (en) * | 1993-07-16 | 1997-09-23 | Smithkline Beecham Corporation | Pyridyl imidazole compounds and compositions |
WO1995013067A1 (en) * | 1993-11-08 | 1995-05-18 | Smithkline Beecham Corporation | Oxazoles for treating cytokine mediated diseases |
US5723477A (en) * | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US6369068B1 (en) | 1995-06-07 | 2002-04-09 | Smithkline Beecham Corporation | Amino substituted pyrimidine containing compounds |
US5739143A (en) * | 1995-06-07 | 1998-04-14 | Smithkline Beecham Corporation | Imidazole compounds and compositions |
ZA9610687B (en) * | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
ZA97175B (en) * | 1996-01-11 | 1997-11-04 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
AP9700912A0 (en) | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
NZ327044A (en) * | 1996-01-11 | 2000-01-28 | Smithkline Beecham Corp | Substituted imidazole compounds |
US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
EP0889888A4 (en) * | 1996-03-25 | 2003-01-08 | Smithkline Beecham Corp | NEW TREATMENT OF LESIONS IN THE CENTRAL NERVOUS SYSTEM |
EP0956018A4 (en) | 1996-08-21 | 2000-01-12 | Smithkline Beecham Corp | IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE |
US5929076A (en) * | 1997-01-10 | 1999-07-27 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
HUP0002842A3 (en) * | 1997-04-24 | 2002-01-28 | Ortho Mcneil Pharm Inc | Substituted imidazoles, process for producing them, pharmaceutical compositions containing them, their use and their intermediates |
EP1023066A4 (en) | 1997-06-13 | 2001-05-23 | Smithkline Beecham Corp | NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND |
US6610695B1 (en) | 1997-06-19 | 2003-08-26 | Smithkline Beecham Corporation | Aryloxy substituted pyrimidine imidazole compounds |
AR016294A1 (es) * | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
US7301021B2 (en) * | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6489325B1 (en) | 1998-07-01 | 2002-12-03 | Smithkline Beecham Corporation | Substituted imidazole compounds |
TW517055B (en) | 1997-07-02 | 2003-01-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds |
US6562832B1 (en) | 1997-07-02 | 2003-05-13 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6251914B1 (en) | 1997-07-02 | 2001-06-26 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
WO1999017776A1 (en) | 1997-10-08 | 1999-04-15 | Smithkline Beecham Corporation | Novel cycloalkenyl substituted compounds |
JP2001526230A (ja) | 1997-12-19 | 2001-12-18 | スミスクライン・ビーチャム・コーポレイション | ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用 |
PL344330A1 (en) * | 1998-05-22 | 2001-10-22 | Smithkline Beecham Corp | Novel 2-alkyl substituted imidazole compounds |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
DE69917296T2 (de) * | 1998-08-20 | 2005-05-25 | Smithkline Beecham Corp. | Neue substituierte triazolverbindungen |
US6548503B1 (en) | 1998-11-04 | 2003-04-15 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
US6239279B1 (en) | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
JP2003514906A (ja) | 1999-11-22 | 2003-04-22 | スミスクライン ビーチャム パブリック リミテッド カンパニー | イミダゾール誘導体およびrafキナーゼ阻害剤としてのその使用 |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
US7053098B1 (en) | 1999-11-23 | 2006-05-30 | Smithkline Beecham Corporation | 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
DE60015599T2 (de) | 1999-11-23 | 2005-11-03 | Smithkline Beecham Corp. | 3,4-DIHYDRO-(1H)CHINAZOLIN-2-ON-VERBINDUNGEN ALS CSBP/p38-KINASE-INHIBITOREN |
AU1782301A (en) | 1999-11-23 | 2001-06-04 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p39 kinase inhibitors |
US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
GB0005357D0 (en) | 2000-03-06 | 2000-04-26 | Smithkline Beecham Plc | Compounds |
EP1263753B1 (en) * | 2000-03-06 | 2004-05-06 | SmithKline Beecham plc | Imidazol derivatives as raf kinase inhibitors |
IL155367A0 (en) * | 2000-10-23 | 2003-12-23 | Smithkline Beecham Corp | NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES |
GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
WO2003022837A1 (en) * | 2001-09-05 | 2003-03-20 | Smithkline Beecham P.L.C. | Heterocycle-carboxamide derivatives as raf kinase inhibitors |
TW200505446A (en) * | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
EP1620406A2 (en) * | 2003-05-08 | 2006-02-01 | Astellas Pharma Inc. | 1,2-diarylimidazoles useful as inhibitors of cox |
US7479558B2 (en) * | 2005-03-25 | 2009-01-20 | Glaxo Group Limited | Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives |
PE20100737A1 (es) * | 2005-03-25 | 2010-11-27 | Glaxo Group Ltd | Nuevos compuestos |
WO2013049272A2 (en) * | 2011-09-29 | 2013-04-04 | Theraceutix, Llc | Composition and method for treatment of symptoms associated with various skin conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558645A (en) * | 1968-07-08 | 1971-01-26 | Sandoz Ag | 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids |
CH561718A5 (ko) * | 1971-05-10 | 1975-05-15 | Ciba Geigy Ag | |
GB1469532A (en) * | 1973-06-28 | 1977-04-06 | Dumex Ltd As | Imimdazolyl-alkanoic acid derivatives |
US4372964A (en) * | 1980-10-30 | 1983-02-08 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols |
-
1981
- 1981-07-23 CA CA000382377A patent/CA1175431A/en not_active Expired
- 1981-07-23 DD DD81232030A patent/DD201677A5/de unknown
- 1981-07-23 GR GR65613A patent/GR75287B/el unknown
- 1981-07-24 ZA ZA815078A patent/ZA815078B/xx unknown
- 1981-07-24 SU SU813317053A patent/SU1235454A3/ru active
- 1981-07-24 PT PT73424A patent/PT73424B/pt unknown
- 1981-07-24 IL IL63410A patent/IL63410A/xx unknown
- 1981-07-24 AU AU73404/81A patent/AU7340481A/en not_active Abandoned
- 1981-07-24 ES ES504257A patent/ES8301472A1/es not_active Expired
- 1981-07-24 NO NO812542A patent/NO812542L/no unknown
- 1981-07-24 IE IE1680/81A patent/IE52071B1/en unknown
- 1981-07-24 FI FI812326A patent/FI812326L/fi not_active Application Discontinuation
- 1981-07-24 DK DK331881A patent/DK331881A/da not_active Application Discontinuation
- 1981-07-24 NZ NZ197828A patent/NZ197828A/en unknown
- 1981-07-24 GB GB8122920A patent/GB2080805B/en not_active Expired
- 1981-07-25 PL PL23700081A patent/PL237000A1/xx unknown
- 1981-07-25 PL PL23699781A patent/PL236997A1/xx unknown
- 1981-07-25 PL PL1981232352A patent/PL135822B1/pl unknown
- 1981-07-25 PL PL23700481A patent/PL237004A1/xx unknown
- 1981-07-25 PL PL23700281A patent/PL237002A1/xx unknown
- 1981-07-25 PL PL23700181A patent/PL237001A1/xx unknown
- 1981-07-25 PL PL23700381A patent/PL237003A1/xx unknown
- 1981-07-25 KR KR1019810002709A patent/KR850000883B1/ko active
- 1981-07-25 PL PL23700581A patent/PL237005A1/xx unknown
- 1981-07-25 JP JP56115896A patent/JPS5756466A/ja active Pending
- 1981-07-27 AT AT81105914T patent/ATE17349T1/de not_active IP Right Cessation
- 1981-07-27 DE DE8181105914T patent/DE3173434D1/de not_active Expired
- 1981-07-27 EP EP81105914A patent/EP0045081B1/de not_active Expired
-
1982
- 1982-07-21 SU SU823465356A patent/SU1205764A3/ru active
- 1982-07-21 SU SU823466067A patent/SU1227112A3/ru active
- 1982-07-21 SU SU823465351A patent/SU1138023A3/ru active
- 1982-07-21 SU SU823466066A patent/SU1145928A3/ru active
- 1982-07-30 ES ES514583A patent/ES514583A0/es active Granted
- 1982-07-30 ES ES514584A patent/ES514584A0/es active Granted
- 1982-07-30 ES ES514580A patent/ES8306120A1/es not_active Expired
- 1982-07-30 ES ES514581A patent/ES8306121A1/es not_active Expired
- 1982-07-30 SU SU823469534A patent/SU1152520A3/ru active
- 1982-07-30 ES ES514579A patent/ES514579A0/es active Granted
- 1982-07-30 ES ES514582A patent/ES514582A0/es active Granted
- 1982-07-30 ES ES514585A patent/ES514585A0/es active Granted
- 1982-07-30 SU SU823468675A patent/SU1169534A3/ru active
- 1982-07-30 DD DD82242110A patent/DD202554A5/de unknown
- 1982-09-28 US US06/425,603 patent/US4447431A/en not_active Expired - Fee Related
- 1982-11-22 AR AR291374A patent/AR230269A1/es active
-
1983
- 1983-07-19 SU SU833618708A patent/SU1205763A3/ru active
-
1984
- 1984-09-27 KR KR1019840005962A patent/KR850000885B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005972A patent/KR850001064B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005971A patent/KR850000892B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005966A patent/KR850000889B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005968A patent/KR850000890B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005960A patent/KR850000873B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005961A patent/KR850000884B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005964A patent/KR850000887B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005965A patent/KR850000888B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005970A patent/KR850000911B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005969A patent/KR850000891B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005963A patent/KR850000886B1/ko active IP Right Grant
-
1986
- 1986-04-23 AU AU56555/86A patent/AU5655586A/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850002744A (ko) | 삼-치환 이미다졸 유도체의 제조방법 | |
JPS5770886A (en) | Imidazole derivative | |
ES505373A0 (es) | Un metodo para preparar derivados de fenilpiperazina | |
IT1138678B (it) | Metodo per fabbricare un pezzo cavo | |
KR850003303A (ko) | 치환된 벤조일-우레아의 제조방법 | |
KR850002010A (ko) | 헤테로사이클릭 화합물의 제조방법 | |
DK370781A (da) | Fremgangsmaade til fremstilling af 3,4-bis-phenyl-1,2,4-triazoler | |
JPS5742688A (en) | Substituted n-alkylimidazole derivative | |
KR850002012A (ko) | 헤테로 사이클릭 유도체의 제조방법 | |
BG35045A3 (en) | Method for preparing substituted triarylthiazolic compounds | |
DK188881A (da) | Fremgangsmaade til fremstilling af 2-guanidinthiazol-derivater | |
DK369181A (da) | Fremgangsmaade til fremstilling af triazolylvinylketonforbindelser | |
ES499135A0 (es) | Un metodo de preparar tiosemicarbazonas sustituidas | |
ES505372A0 (es) | Un metodo de preparar derivados de fenil-piperazina | |
KR850003384A (ko) | 9-카바모일플루오렌 유도체의 제조방법 | |
KR850003301A (ko) | 옥소옥세판 유도체의 합성방법 | |
KR850002757A (ko) | 사이클로 펜텐 유도체의 제조방법 | |
KR850001460A (ko) | 테트라졸 유도체의 제조방법 | |
KR850000179A (ko) | 세파피린 에스테르의 제조방법 | |
JPS56169693A (en) | Novel imidazole derivative | |
KR850003297A (ko) | 티아졸린 유도체의 제조방법 | |
NO811452L (no) | Imidazolderivater. | |
BA97177B1 (bs) | Psotupak za primjenu novih jedinjenja triazola i imidazola | |
KR860002947A (ko) | α-술포닐옥시케톤 아세탈의 제조방법 | |
ES503979A0 (es) | Un procedimiento de preparacion de un derivado de la piridi-na |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |